The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
The validation of visual analogue scales as ratio scale measures for chronic and experimental pain
Price, D. D., McGrath, P. A., Rafii, A., & Buckingham, B. (1983) · Pain · doi:10.1016/0304-3959(83)90126-4 · Cited by 3,921
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Reich, K., Nestle, F. O., Papp, K., Ortonne, J.-P., Evans, R., Guzzo, C., Li, S., Dooley, L. T., & Griffiths, C. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045
Gottlieb, A. B., Evans, R., Li, S., Dooley, L. T., Guzzo, C. A., Baker, D., Bala, M., Marano, C. W., & Menter, A. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.021 · Cited by 581
Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K., Evans, R., Guzzo, C., Li, S., Dooley, L. T., Arnold, C., & Gottlieb, A. B. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516
The prevalence of hidradenitis suppurativa and its potential precursor lesions
Jemec, G. B. E., Heidenheim, M., & Nielsen, N. H. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90321-7 · Cited by 508
Quality of life impairment in hidradenitis suppurativa: A study of 61 cases
Wolkenstein, P., Loundou, A., Barrau, K., Auquier, P., & Revuz, J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.061 · Cited by 369
Morbidity in patients with hidradenitis suppurativa
Von Der Werth, J. M., & Jemec, G. B. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04137.x · Cited by 344
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa
Jemec, G. B. E., & Wendelboe, P. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70272-5 · Cited by 338
Hidradenitis suppurativa: pathogenesis and management
Slade, D. E. M., Powell, B. W., & Mortimer, P. S. (2003) · British Journal of Plastic Surgery · doi:10.1016/s0007-1226(03)00177-2 · Cited by 290
Sartorius, K., Lapins, J., Emtestam, L., & Jemec, G. B. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05390.x · Cited by 252
The clinical genetics of hidradenitis suppurativa revisited
Von Der Werth, J. M., Williams, H. C., & Raeburn, J. A. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03476.x · Cited by 195
Shalita, A. R. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.03.012 · Cited by 184
KRISTENSEN, M., CHU, C. Q., EEDY, D. J., FELDMANN, M., BRENNAN, F. M., & BREATHNACH, S. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb03457.x · Cited by 171
Cusack, C., & Buckley, C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07067.x · Cited by 171
Hidradenitis Suppurativa and Crohn's Disease: Response to Treatment with Infliximab
Martínez, F., Nos, P., Benlloch, S., & Ponce, J. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200111000-00008 · Cited by 163
The Bacteriology of Hidradenitis suppurativa
Jemec, G. B. E., Faber, M., Gutschik, E., & Wendelboe, P. (1996) · Dermatology · doi:10.1159/000246246 · Cited by 159
Infliximab for hidradenitis suppurativa
Sullivan, T. P., Welsh, E., Kerdel, F. A., Burdick, A. E., & Kirsner, R. S. (2003) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2003.05663.x · Cited by 158
Self-citationEvidence of genetic factors in hidradenitis suppurativa
Fitzsimmons, J. S., Guilbert, P., & Fitzsimmons, E. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb02037.x · Cited by 148
Mediation of hidradenitis suppurativa by androgens.
Mortimer, P. S., Dawber, R. P. R., GALES, M. A., & Moore, R. A. (1986) · BMJ · doi:10.1136/bmj.292.6515.245 · Cited by 139
Fardet, L., Dupuy, A., Kérob, D., Levy, A., Allez, M., Bégon, E., Bachelez, H., Morel, P., & Lebbé, C. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.027 · Cited by 128
Acne inversa (alias hidradenitis suppurativa)
Jansen, T., Altmeyer, P. J., & Plewig, G. (2001) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2001.00303.x · Cited by 127
Altered innate and adaptive immune responses in patients with hidradenitis suppurativa
Giamarellos‐Bourboulis, E. J., Antonopoulou, A., Petropoulou, C., Mouktaroudi, M., Spyridaki, E., Baziaka, F., Πελεκάνου, Α., Giamarellou, H., & Stavrianeas, N. G. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07556.x · Cited by 125
Giamarellos‐Bourboulis, E. J., Pelekanou, E., Antonopoulou, A., et al. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08372.x · Cited by 124
Gao, M., Wang, P., Cui, Y., Yang, S., Zhang, Y., Lin, D., Zhang, K.-Y., Liang, Y., Sun, L., Yan, K., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700272 · Cited by 109
Serious Adverse Events With Infliximab: Analysis of Spontaneously Reported Adverse Events
Hansen, R. A., Gartlehner, G., Powell, G. E., & Sandler, R. S. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.016 · Cited by 108
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
Mekkes, J. R., & Bos, J. D. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08332.x · Cited by 105
Infliximab: An Updated Review of its Use in Crohn??s Disease and Rheumatoid Arthritis
Keating, G. M., & Perry, C. M. (2002) · BioDrugs · doi:10.2165/00063030-200216020-00005 · Cited by 102
Severe Hidradenitis Suppurativa Treated With Infliximab Infusion
Adams, D. R. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1540 · Cited by 97
Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient
Katsanos, K. H., Christodoulou, D. K., & Tsianos, E. V. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05950.x · Cited by 93
Rycroft, R., Robertson, S., & Wakelin, S. (2010) · Dermatology · doi:10.1201/9781840765960-11 · Cited by 91
Cyclosporin-responsive hidradenitis suppurativa.
Buckley, D. A., & Rogers, S. (1995) · Europe PMC (PubMed Central) · Cited by 85
Infliximab for the treatment of hidradenitis suppurativa
Lebwohl, B., & Sapadin, A. N. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01132-0 · Cited by 80
Methotrexate is of limited value in the treatment of hidradenitis suppurativa
Jemec, G. B. E. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.11125.x · Cited by 73
Roussomoustakaki, M., Dimoulios, P. D., Chatzicostas, C., Kritikos, H. D., Romanos, J., Panayiotides, J. G., & Kouroumalis, E. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1185-9 · Cited by 72
Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease
Rosi, Y. L., Lowe, L., & Kang, S. (2005) · Journal of Dermatological Treatment · doi:10.1080/09546630410024547 · Cited by 72
Stern, R., & Wolfe, F. (2004) · PubMed · Cited by 68
The homogeneity of hidradenitis suppurativa lesions
Jemec, G. B. E., Thomsen, B. M., & HANSEN, U. (1997) · Apmis · doi:10.1111/j.1699-0463.1997.tb00584.x · Cited by 67
Arthritis associated with hidradenitis suppurativa.
Bhalla, R., & Sequeira, W. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.1.64 · Cited by 66
Medical treatment of hidradenitis suppurativa
Jemec, G. B. E. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.8.1767 · Cited by 61
Moschella, S. L. (2007) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2007.03293.x · Cited by 53
Infliximab for the Treatment of Hidradenitis Suppurativa
Fernández-Vozmediano, J. M., & Armario-Hita, J. C. (2007) · Dermatology · doi:10.1159/000102032 · Cited by 47
Revuz, J. E. (2007) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(07)91613-0 · Cited by 41
Bacteriology of Hidradenitis Suppurativa
Oprica, C., & Nord, C. E. (2006) · Springer eBooks · doi:10.1007/978-3-540-33101-8_11 · Cited by 15
Place de la chirurgie dans le traitement de l’hidradénite suppurée
Revuz, J. (2008) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2008.03.003 · Cited by 7
Cited by
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E. P., Revuz, J., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12966 · Cited by 1,093
Jemec, G. B. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1014163 · Cited by 817
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., Armstrong, A. W., Kerdel, F., Gold, M. H., Forman, S. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504370 · Cited by 807
Self-citationSabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Goldburg, S. R., Strober, B. E., & Payette, M. J. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.08.090 · Cited by 486
Metadata
- Authors
- Grant, A., Gonzalez, T., Montgomery, M. O., Cardenas, V., & Kerdel, F. A.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 62
- Issue
- 2
- Pages
- 205-217
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2041193055
- Cited by
- 419
- References
- 48
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.